B
CL icon

Bellecapital’s Colgate-Palmolive CL Stock Holding History

Bellecapital’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5,252
Closed -$421K – 191
2022
Q2 		$421K Hold
5,252
– – 0.12% 129
2022
Q1 		$398K Buy
5,252
+300
+6% +$23.8K 0.13% 130
2021
Q4 		$423K Hold
4,952
– – 0.12% 133
2021
Q3 		$374K Hold
4,952
– – 0.11% 149
2021
Q2 		$403K Sell
4,952
-300
-6% -$24.5K 0.12% 135
2021
Q1 		$414K Sell
5,252
-10,742
-67% -$842K 0.13% 127
2020
Q4 		$1.37M Buy
15,994
+13,225
+478% +$1.09M 0.46% 48
2020
Q3 		$214K Hold
2,769
– – 0.1% 154
2020
Q2 		$203K Buy
+2,769
New +$197K 0.1% 153
2019
Q4 		– Sell
-2,769
Closed -$204K – 149
2019
Q3 		$204K Buy
+2,769
New +$201K 0.12% 125

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bellecapital's CL Position: Q3 2022 in Review

Bellecapital sold out of Colgate-Palmolive (CL) in Q3 2022, closing a stake of 5,252 shares — an estimated $421K sold.

Bellecapital first reported a position in CL in Q3 2019 and held it in 10 quarters. The position peaked at $1.37M in Q4 2020. 1,614 funds tracked by Wall St. Rank hold CL as of Q3 2022.

  • Bellecapital reported no remaining Colgate-Palmolive position as of Q3 2022 after selling out during the quarter.
  • Bellecapital sold 5,252 Colgate-Palmolive shares in Q3 2022, an estimated $421K.
  • Bellecapital first reported a position in Colgate-Palmolive in Q3 2019 and held it in 10 quarters.
  • Bellecapital's Colgate-Palmolive position peaked at $1.37M in Q4 2020.
  • 1,614 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2022.

Based on Bellecapital's 13F filing for Q3 2022, filed 7 Nov 2022.